Treatment of relapsed undifferentiated acute myeloid leukemia (AML-M0) with Ayurvedic therapy.

Balendu Prakash
{"title":"Treatment of relapsed undifferentiated acute myeloid leukemia (AML-M0) with Ayurvedic therapy.","authors":"Balendu Prakash","doi":"10.4103/0974-7788.83184","DOIUrl":null,"url":null,"abstract":"<p><p>A 16-year-old boy was detected with acute myeloid leukemia (AML - M0) with bone marrow pathology showing 85% blasts in February 07, 1997. He received two cycles of induction chemotherapy (3+7 protocol) with daunomycin and cytosar, following which he achieved incomplete remission with bone marrow aspirate showing 14% blasts. Subsequently, the patient received two cycles of high-dose cytosine arabinoside Ara-C and achieved remission. However, his disease relapsed on August 29, 1997. Peripheral blood smear showed 6% blast cells and bone marrow showed 40% blast cells. The patient refused further chemotherapy and/or bone marrow transplant and volunteered for Ayurvedic therapy (AYT) advocated by the author from September 09, 1997. Bone marrow studies done after six months of AYT indicated that the disease was in remission. The AYT was continued for five years and stopped. Thereafter, the patient received intermittent maintenance AYT for three months in the next two years. At present, the patient is normal and healthy and has completed 12 years of disease-free survival with AYT.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"2 1","pages":"56-9"},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.83184","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of Ayurveda research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/0974-7788.83184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 14

Abstract

A 16-year-old boy was detected with acute myeloid leukemia (AML - M0) with bone marrow pathology showing 85% blasts in February 07, 1997. He received two cycles of induction chemotherapy (3+7 protocol) with daunomycin and cytosar, following which he achieved incomplete remission with bone marrow aspirate showing 14% blasts. Subsequently, the patient received two cycles of high-dose cytosine arabinoside Ara-C and achieved remission. However, his disease relapsed on August 29, 1997. Peripheral blood smear showed 6% blast cells and bone marrow showed 40% blast cells. The patient refused further chemotherapy and/or bone marrow transplant and volunteered for Ayurvedic therapy (AYT) advocated by the author from September 09, 1997. Bone marrow studies done after six months of AYT indicated that the disease was in remission. The AYT was continued for five years and stopped. Thereafter, the patient received intermittent maintenance AYT for three months in the next two years. At present, the patient is normal and healthy and has completed 12 years of disease-free survival with AYT.

Abstract Image

阿育吠陀疗法治疗复发性未分化急性髓性白血病(AML-M0)。
1997年2月7日,一名16岁的男孩被发现患有急性髓性白血病(AML - M0),骨髓病理显示85%的细胞。他接受了两个周期的诱导化疗(3+7方案),使用道诺霉素和细胞沙,之后他实现了不完全缓解,骨髓抽吸显示14%的细胞。随后,患者接受了两个周期的高剂量阿拉伯糖胞嘧啶Ara-C治疗并获得缓解。然而,他的疾病于1997年8月29日复发。外周血涂片示母细胞6%,骨髓示母细胞40%。患者拒绝进一步化疗和/或骨髓移植,自1997年9月9日起自愿接受作者倡导的阿育吠陀疗法(AYT)。接受AYT治疗6个月后进行的骨髓研究表明,病情有所缓解。AYT持续了5年,然后停止了。此后,患者在接下来的两年里接受了3个月的间歇性维持性AYT。目前,患者正常健康,采用AYT已完成12年无病生存期。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信